SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Stock Hong Kong S.E.
Equities
2196
CNE100001M79
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.58 HKD | +1.19% |
|
-0.59% | -20.12% |
| Sales 2024 * | 43.96B 6.06B 47.33B | Sales 2025 * | 48.54B 6.69B 52.27B | Capitalization | 54.7B 7.54B 58.89B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.5B 483M 3.77B | Net income 2025 * | 3.96B 546M 4.26B | EV / Sales 2024 * | 1.6 x |
| Net Debt 2024 * | 15.46B 2.13B 16.65B | Net Debt 2025 * | 17.72B 2.44B 19.08B | EV / Sales 2025 * | 1.49 x |
| P/E ratio 2024 * |
17.7
x | P/E ratio 2025 * |
14.4
x | Employees | 40,370 |
| Yield 2024 * |
1.78% | Yield 2025 * |
2.13% | Free-Float | 63.46% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +1.19% | ||
| 1 week | -0.59% | ||
| Current month | +2.72% | ||
| 1 month | +0.15% | ||
| 3 months | +14.70% | ||
| 6 months | -17.50% | ||
| Current year | -20.12% |
1 week
13.04
13.96
1 month
12.7613.96
Current year
11.3217.18
1 year
11.3221.25
3 years
11.3282.00
5 years
11.3282.00
10 years
11.3282.00
| Managers | Title | Age | Since |
|---|---|---|---|
De Yong Wen
CEO | Chief Executive Officer | 52 | - |
Shirley Wu
DFI | Director of Finance/CFO | 44 | 16-12-31 |
Dong Ming Li
PSD | President | 55 | 20-10-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Qi Yu Chen
BRD | Director/Board Member | 52 | 94-03-31 |
Yi Min Guan
BRD | Director/Board Member | 74 | 07-05-27 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.37% | 4 M€ | -27.92% | ||
| 0.63% | 1 M€ | -22.82% | - | |
| 0.21% | 2 M€ | +1.90% | - | |
| 0.18% | 2 M€ | -14.14% | ||
| 0.16% | 4 M€ | -11.56% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-12 | 13.58 | +1.19% | 4 527 288 |
| 24-07-11 | 13.42 | +1.82% | 3,735,500 |
| 24-07-10 | 13.18 | -0.90% | 4,115,650 |
| 24-07-09 | 13.3 | +0.15% | 4,184,282 |
| 24-07-08 | 13.28 | -2.78% | 3,633,000 |
Delayed Quote Hong Kong S.E., July 12, 2024 at 04:08 am EDT
More quotes
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical group organized around 4 areas of activities:
- research, development and manufacturing of medicines (72.1% of net sales): for the treatment of cardiovascular diseases, digestive tract, metabolism, central nervous system and blood system disorders, and infectious diseases;
- sale of medical equipments and diagnosis products (17.3%);
- medical and hospital services (10.5%);
- other (0.1%).
China accounts for 72.9% of net sales.
Sector
Pharmaceuticals
Calendar
2024-08-27
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
22.57
CNY
Average target price
28.61
CNY
Spread / Average Target
+26.75%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +60.25% | 841B | |
| +38.99% | 625B | |
| -4.49% | 360B | |
| +18.30% | 327B | |
| +9.64% | 300B | |
| +15.49% | 242B | |
| +4.05% | 228B | |
| +18.46% | 227B | |
| +12.87% | 174B |
- Stock Market
- Equities
- 600196 Stock
- 2196 Stock